New Weight Loss Pill Cuts Body Weight By 20%
Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.
Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.
Former chief scientific adviser Sir Patrick Vallance warns that dwindling investment in medical research and innovation threatens the future of the NHS and patient care. Discover the urgent call for action.
Pharmaceutical giant Merck to manufacture flagship cancer drug Lynparza at new €1 billion Irish facility, dealing significant blow to UK's life sciences sector and raising fresh post-Brexit trade concerns.
Exclusive analysis reveals how a potential Trump presidency could jeopardise Britain's NHS medicine pricing, forcing UK patients to pay US-style pharmaceutical costs.
Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.
Pharmaceutical giant AstraZeneca has paused plans for its new £500 million global headquarters in Cambridge, citing an 'unfavourable' UK economic climate and sending shockwaves through the business community.
Hollywood giant Paramount Pictures faces a major industry backlash and boycott calls after signing a lucrative co-production deal with Israel, as the Gaza conflict continues.
Groundbreaking research uncovers a disturbing correlation between widely prescribed drugs, including beta-blockers and anti-anxiety medications, and a sharp increase in suicide risks and depression in children and young adults. Experts are calling for urg
Pharmaceutical giant AstraZeneca pauses its major £200m Cambridge research centre expansion, citing global strategic review and UK economic uncertainty in post-Brexit landscape.
Sanofi executive warns of UK's worsening medicines access crisis, citing post-Brexit regulations, NICE hurdles, and a pricing system that deters investment and innovation.
Pharmaceutical giant MSD, known as Merck in the US, is significantly expanding its UK presence with a new state-of-the-art research hub in London, generating over 125 new high-skilled jobs and reinforcing the city's status as a global life sciences leader
Exclusive report reveals Donald Trump pressured US health officials to accelerate vaccine approval for political gain ahead of the 2020 election, according to congressional investigation.
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
A tense US Congressional hearing investigates a surge in severe neurological illnesses in children following vaccination, as lawmakers demand answers from pharmaceutical executives.
Danish pharmaceutical giant Novo Nordisk's market value skyrockets past £400bn, briefly eclipsing the entire Danish economy, on the back of soaring demand for its blockbuster weight-loss drug, Wegovy.
German authorities have confiscated thousands of doses of the in-demand weight-loss medication Wegovy from a Frankfurt wholesaler, citing illegal parallel imports from outside the EU and improper storage conditions.
A 13-year-old girl from Northern Ireland tragically passed away just days after being prescribed a new asthma medication. Her devastated family is now demanding answers from health authorities.
Groundbreaking medical research reveals a new anti-inflammatory drug shows no significant advantage over traditional aspirin for heart attack prevention in most patients, challenging pharmaceutical expectations.
In a landmark move for public health, California, Oregon, and Washington announce a unified 'West Coast Pact' to independently review COVID-19 vaccines, prioritising safety and science over political pressure.
The CEO of Pfizer has alleged that former President Donald Trump directly suggested he should be awarded a Nobel Prize for his role in the rapid development of the COVID-19 vaccine, a revelation that has sent shockwaves through political and scientific ci
Podcast titan Joe Rogan ignites a fierce debate by citing controversial research connecting widely prescribed antidepressants to the epidemic of mass shootings. This investigation delves into the science and the silenced studies.
Uganda has inaugurated Africa's first major mRNA vaccine facility, a historic step towards medical self-reliance, combating diseases from COVID-19 to HIV, and reducing the continent's dependency on foreign pharmaceuticals.
US Presidential candidate Robert F. Kennedy Jr. launches a scathing attack on the CDC, accusing it of corruption and being a 'captured agency' of the pharmaceutical industry in a bombshell op-ed.
An in-depth look at the 'nepo baby' phenomenon sweeping the entertainment industry, from Hollywood to the UK. Discover how celebrity children are taking over film, music, and directing roles, and the fierce debate it's sparking about privilege and talent.
A nationwide manhunt is underway for a woman allegedly selling fake diabetes and weight-loss medications online. Authorities warn of severe health risks from counterfeit semaglutide injections.
In a fiery debate revelation, Donald Trump accuses pharmaceutical giants of a COVID-19 cover-up, vowing to force transparency on the pandemic's origins if re-elected. RFK Jr. backs the claim, igniting a new political firestorm.
A groundbreaking new hypertension drug, Baxdrostat, developed by AstraZeneca, has demonstrated remarkable success in clinical trials, potentially offering new hope for millions with treatment-resistant high blood pressure in the UK.
Former President Trump's proposed tariffs could severely restrict UK supplies and drastically increase prices for diabetes and weight-management medications like Ozempic, Wegovy, and Mounjaro, creating a new healthcare crisis.
Eli Lilly suspends shipments of obesity drug Mounjaro to the UK, triggering a major price surge and leaving thousands of patients in limbo amid supply chain restructuring.
Health Secretary Wes Streeting takes hardline stance in crucial NHS drug pricing negotiations with pharmaceutical giants, demanding better value for taxpayers while facing industry resistance.